COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
28/11/2018
– AITL patent expands protection for tipifarnib, provides exclusivity in U.S. to 2037 – – Prospective data from AITL and CXCL12+ cohorts in Phase 2 trial of tipifarnib in PTCL upcoming at ASH 2018 – SAN DIEGO, Nov. 28, [...]
Orion Corporation: Managers' transactions - Agendum Oy
28/11/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 28 November 2018 at 14.15 EET Orion Corporation: Managers' transactions - Agendum Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Epistem completes board line up and launches new NGS service
28/11/2018
MANCHESTER, United Kingdom, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Epistem Limited , the Manchester based pre-clinical and clinical research services company announces the completion of its Board appointments. Benjamin Reed [...]
Aclaris Therapeutics to Attend Upcoming Investor Conferences
28/11/2018
WAYNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Emerald Health Therapeutics Announces Executive Chairman Avtar Dhillon Appointed as President; CEO Chris Wagner Steps Down
28/11/2018
VICTORIA, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced today that Dr. Avtar Dhillon, Executive Chairman, has been [...]
Medigus Announces Third Quarter 2018 Financial Results
28/11/2018
OMER, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization [...]
Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event during ASH 2018
28/11/2018
-Event on December 2 in San Diego, CA with Slide Webcast- SOUTH SAN FRANCISCO, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced it will provide a program update for [...]
Share issue / transfer in connection with reduction of the quantity of shares in Nexstim Plc
28/11/2018
Company announcement, Helsinki, 28 November 2018 at 13:30 Share issue / transfer in connection with reduction of the quantity of shares in Nexstim Plc The Extraordinary General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS: [...]
ChromaDex to Present at the 11th Annual LD Micro Main Event
28/11/2018
LOS ANGELES, Nov. 28, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, Co-Founder & Executive Chairman, Frank Jaksch, and Chief Financial Officer, [...]
Affimed to Host Research & Development Day on Friday, December 7, 2018 in New York City
28/11/2018
Heidelberg, Germany, November 28, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of [...]
Invivoscribe soumet le test de mutation LeukoStrat CDx FLT3 à la fois aux États-Unis et au Japon pour soutenir la soumission de Daiichi Sankyo pour le quizartinib
28/11/2018
SAN DIEGO, 28 nov. 2018 (GLOBE NEWSWIRE) -- En soutien à un partenariat en cours avec Daiichi Sankyo, Invivoscribe a le plaisir d’annoncer la soumission du test de mutation LeukoStrat ® CDx FLT3 à la fois à la FDA aux [...]
Aquarius Surgical Technologies Announces Appointment of Mr. Gordon Willox as President & CTO, and the Closing of Funding Transaction
28/11/2018
TORONTO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Aquarius Surgical Technologies Inc. (ASTI – CSE) (“the Corporation”) is pleased to announce that Mr. Gordon Willox, has been appointed to the position of President and Chief [...]
Olainfarm invites to Third Quarter 2018 Investor Conference Webinar
28/11/2018
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on December 6, 2018 at 16:00 (EEST). To join the webinar please follow [...]
Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization
28/11/2018
To Accelerate Precision Medicine Through Globally Proven Experience PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu), a [...]
INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing
28/11/2018
The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands into new markets VANCOUVER, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- bioLytical Laboratories , a world leader in rapid infectious [...]
B-Temia and Wistron Announce the Incorporation of B-Temia Asia
28/11/2018
B-Temia Asia will launch human mobility device Keeogo(TM) in the Asia Market QUÉBEC CITY, Nov. 28, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. today announced the official incorporation of B-Temia Asia Pte. Ltd., as a result [...]
B-Temia et Wistron annoncent la création de B-Temia Asia
28/11/2018
B-Temia Asia lancera le Keeogo(TM), son appareil de mobilité humaine sur le marché asiatique QUÉBEC, 28 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. a annoncé aujourd’hui la création officielle de B-Temia Asia Pte. Ltd., [...]
ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes
28/11/2018
Geneva, Switzerland and Boston, MA – November 28, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
B-Temia and Wistron Announce the Incorporation of B-Temia Asia
28/11/2018
B-Temia Asia will launch human mobility device Keeogo(TM) in the Asia Market QUÉBEC CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. today announced the official incorporation of B-Temia Asia Pte. Ltd., as a result [...]

Pages